Monitor for further insider selling or any negative corporate news. While the stock has shown resilience after prior neutral reports, large CEO sales often precede periods of underperformance. Watch next 10-Q for any fundamental deterioration.
ONC drugs
ONC drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 15 $311.26entry
- T+1 · 4mo ago +1.98%α +2.52% · $317.42
- T+5 · 4mo ago +2.79%α +3.77% · $319.93
- T+20 · 3mo ago +15.35%α +13.01% · $359.05
- T+60 · 6w ago +12.49%α +9.95% · $350.13
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BeOne Medicines CEO John Oyler sold 4,139 shares and General Counsel Lee Chan Henry sold 664 shares, totaling $1.46M in this filing. However, broader Form 4 filings over the past week reveal Oyler sold over $47M in stock (~0.14% of market cap), a notable insider selling cluster. While insider sales are less predictive than buys, the magnitude and executive-level concentration warrant caution.
Key Financial Metrics
Key Facts
- CEO John Oyler sold 4,139 shares at $303.07 in this filing
- General Counsel Lee Chan Henry sold 664 shares at $302.46
- Total reported sell value: $1.46M (0.004% of market cap)
- Cross-filing context shows Oyler sold >$47M in open-market sales over July 10-14, 2026
- Market cap: $33.8B; analyst consensus 92% bullish
Financial Impact
CEO selling of ~$47M represents 0.14% of $33.8B market cap, modest but notable for a single insider
Risk Factors
- CEO selling may be for tax or diversification, not a signal of distress
- Historical insider sales are weak predictors on average
- Stock has strong analyst support (92% bullish) which could offset bearish sentiment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ONC-1784080888763 |
Track record
27 reports on ONC
3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers